Keratoconus patient now legal to drive, day or night after CXL (Collagen Crosslinking)

Keratoconus is a rare eye condition that REQUIRES treatment or results in needing a corneal transplant if the disease is left untreated for too long. Marc had collagen cross linking (CXL), a procedure that has been FDA approved for well over a decade now. Dr Emil Chynn, given his reputation as a world renowned surgeon, participated in the original clinical studies that resulted in FDA approval and has treated thousands of patients just like Marc throughout his career
Certain medical insurances can cover part or all of the cost of CXL, while some cover partial payment. For those without insurance the procedure is very affordable and very necessary. Call us at 212-741-8628 to find out more and book an appointment to what your options are to keep your vision and your eyes